Yingnan Chen

4PUBLICATIONS
57CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy.

|Jan 31, 2025
Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency.

Antoine Simoneau, Charlotte B Pratt, Hsin-Jung Wu

|Oct 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.

Antoine Simoneau, Justin L Engel, Madhavi Bandi

|Sep 07, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma.

Julie A Shields, Samuel R Meier, Madhavi Bandi

Pageof 1

Frequent Collaborators

4 joint publications

Jannik N Andersen

3 joint publications

Alan Huang

3 joint publications

Wenhai Zhang

3 joint publications

Minjie Zhang